Today's Topline - 5/22/20
Friday, May 22, 2020
Source: MedTech Association
Good Friday morning:
This week ends with hopeful news in the development of a COVID-19 vaccine. The New York Times reports that in labs around the world, there is cautious optimism that a vaccine, and perhaps more than one, will be ready sometime next year. Scientists are exploring at least four different approaches, and initial indications are encouraging. While the history of vaccine development is filled with stories of promising candidates that failed to live up to early expectations, the stable nature of this pathogen, and the multi-pronged effort to combat it, make it more likely that an effective vaccine will be ready soon.
Longtime MedTech member MPR Associates is a leader in developing innovative medical devices and biotechnology products that offer solutions to world health problems. Jeff Champagne, MPR’s Director of Business Development, describes himself as a medical technology and life science product development Sherpa. He works with companies and innovators to solve their biggest product development challenges. Jeff and the MPR team are valuable connectors and problem-solvers for New York’s bio/med industry. This upcoming week, MPR will be featured on DeviceTalks Tuesday, hosted by our friends at MassDevice. They’ll be talking about their collaboration with Maculogix and the process of putting diagnostics into small, wearable devices. We encourage you to check it out.
MedTech exists to deliver value to the bio/med industry and serve those on the front lines of healthcare advances. We rely on our members to make that possible. Please take a moment to join or renew your membership today. Renewing members can lock in last year’s rate through 2021. New members who join today will receive 3 free months on their membership year. Don’t wait. We need your support to continue the work we do.